Skip to main content

Advertisement

SpringerLink
Log in

LEF1 regulates glioblastoma cell proliferation, migration, invasion, and cancer stem-like cell self-renewal

  • Research Article
  • Published:
Tumor Biology

Abstract

Glioblastoma multiforme (GBM; WHO grade IV) is one of the most common primary tumors of the central nervous system. This disease remains one of the incurable human malignancies because the molecular mechanism driving the GBM development and recurrence is still largely unknown. Here, we show that knockdown of lymphocyte enhancer factor-1 (LEF1), a major transcription factor of Wnt pathway, inhibits U251 cell migration, invasion, and proliferation. Furthermore, downregulation of LEF1 expression inhibits the self-renewal capacity of U251 GBM stem-like cells and decreases the expression level of the GBM stem-like cell (GSC) markers such as CD133 and nestin. Our findings reveal that LEF1 maintains the GBM cell proliferation, migration, and GBM stem-like cell self-renewal. Taken together, these results suggest that LEF1 may be a novel therapeutic target for GBM suppression.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5

Similar content being viewed by others

References

  1. Davis FG, McCarthy BJ. Current epidemiological trends and surveillance issues in brain tumors. Expert Rev Anticancer Ther. 2001;1:395–401.

    Article  CAS  PubMed  Google Scholar 

  2. Teodorczyk M, Martin-Villalba A. Sensing invasion: cell surface receptors driving spreading of glioblastoma. J Cell Physiol. 2010;222:1–10.

    Article  CAS  PubMed  Google Scholar 

  3. Nakano I, Kornblum HI. Brain tumor stem cells. Pediatr Res. 2006;59:54R–8R.

    Article  PubMed  Google Scholar 

  4. Vescovi AL, Galli R, Reynolds BA. Brain tumour stem cells. Nat Rev Cancer. 2006;6:425–36.

    Article  CAS  PubMed  Google Scholar 

  5. Tu Y, Gao X, Li G, Fu H, Cui D, Liu H, et al. MicroRNA-218 inhibits glioma invasion, migration, proliferation, and cancer stem-like cell self-renewal by targeting the polycomb group gene Bmi1. Cancer Res. 2013;73:6046–55.

    Article  CAS  PubMed  Google Scholar 

  6. Li J, Gong LY, Song LB, Jiang LL, Liu LP, Wu J, et al. Oncoprotein Bmi-1 renders apoptotic resistance to glioma cells through activation of the IKK-nuclear factor-kappab pathway. Am J Pathol. 2010;176:699–709.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  7. Gao X, Jin W (2014) The emerging role of tumor-suppressive microRNA-218 in targeting glioblastoma stemness. Cancer Lett

  8. Fodde R, Brabletz T. Wnt/beta-catenin signaling in cancer stemness and malignant behavior. Curr Opin Cell Biol. 2007;19:150–8.

    Article  CAS  PubMed  Google Scholar 

  9. Jin X, Jeon HY, Joo KM, Kim JK, Jin J, Kim SH, et al. Frizzled 4 regulates stemness and invasiveness of migrating glioma cells established by serial intracranial transplantation. Cancer Res. 2011;71:3066–75.

    Article  CAS  PubMed  Google Scholar 

  10. Petropoulos K, Arseni N, Schessl C, Stadler CR, Rawat VP, Deshpande AJ, et al. A novel role for LEF-1, a central transcription mediator of Wnt signaling, in leukemogenesis. J Exp Med. 2008;205:515–22.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  11. Liu Y, Yan W, Zhang W, Chen L, You G, Bao Z, et al. Mir-218 reverses high invasiveness of glioblastoma cells by targeting the oncogenic transcription factor LEF1. Oncol Rep. 2012;28:1013–21.

    PubMed  Google Scholar 

  12. Qiang L, Yang Y, Ma YJ, Chen FH, Zhang LB, Liu W, et al. Isolation and characterization of cancer stem like cells in human glioblastoma cell lines. Cancer Lett. 2009;279:13–21.

    Article  CAS  PubMed  Google Scholar 

  13. Mi YJ, Hou B, Liao QM, Ma Y, Luo Q, Dai YK, et al. Amino-Nogo-a antagonizes reactive oxygen species generation and protects immature primary cortical neurons from oxidative toxicity. Cell Death Differ. 2012;19:1175–86.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  14. Tropepe V, Sibilia M, Ciruna BG, Rossant J, Wagner EF, van der Kooy D. Distinct neural stem cells proliferate in response to EGF and FGF in the developing mouse telencephalon. Dev Biol. 1999;208:166–88.

    Article  CAS  PubMed  Google Scholar 

  15. Giese A, Bjerkvig R, Berens ME, Westphal M. Cost of migration: invasion of malignant gliomas and implications for treatment. J Clin Oncol Off J Am Soc Clin Oncol. 2003;21:1624–36.

    Article  CAS  Google Scholar 

  16. Anastas JN, Moon RT. Wnt signalling pathways as therapeutic targets in cancer. Nat Rev Cancer. 2013;13:11–26.

    Article  CAS  PubMed  Google Scholar 

  17. He TC, Sparks AB, Rago C, Hermeking H, Zawel L, da Costa LT, et al. Identification of c-MYC as a target of the APC pathway. Science. 1998;281:1509–12.

    Article  CAS  PubMed  Google Scholar 

  18. Conacci-Sorrell ME, Ben-Yedidia T, Shtutman M, Feinstein E, Einat P, Ben-Ze’ev A. Nr-cam is a target gene of the beta-catenin/LEF-1 pathway in melanoma and colon cancer and its expression enhances motility and confers tumorigenesis. Genes Dev. 2002;16:2058–72.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  19. Shtutman M, Zhurinsky J, Simcha I, Albanese C, D’Amico M, Pestell R, et al. The cyclin D1 gene is a target of the beta-catenin/LEF-1 pathway. Proc Natl Acad Sci U S A. 1999;96:5522–7.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  20. Ingraham CA, Park GC, Makarenkova HP, Crossin KL. Matrix metalloproteinase (MMP)-9 induced by Wnt signaling increases the proliferation and migration of embryonic neural stem cells at low O2 levels. J Biol Chem. 2011;286:17649–57.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  21. Cenci T, Martini M, Montano N, D’Alessandris QG, Falchetti ML, Annibali D, et al. Prognostic relevance of c-MYC and BMI1 expression in patients with glioblastoma. Am J Clin Pathol. 2012;138:390–6.

    Article  CAS  PubMed  Google Scholar 

  22. Yamaki T, Suenaga Y, Iuchi T, Alagu J, Takatori A, Itami M, et al. Temozolomide suppresses MYC via activation of TAp63 to inhibit progression of human glioblastoma. Sci Rep. 2013;3:1160.

    Article  PubMed Central  PubMed  Google Scholar 

  23. Zhang X, Zhao M, Huang AY, Fei Z, Zhang W, Wang XL. The effect of cyclin D expression on cell proliferation in human gliomas. J Clin Neurosci Off J Neurosurg Soc Australas. 2005;12:166–8.

    CAS  Google Scholar 

  24. Arato-Ohshima T, Sawa H. Over-expression of cyclin D1 induces glioma invasion by increasing matrix metalloproteinase activity and cell motility. Int J Cancer. 1999;83:387–92.

    Article  CAS  PubMed  Google Scholar 

  25. Sehgal A, Boynton AL, Young RF, Vermeulen SS, Yonemura KS, Kohler EP, et al. Cell adhesion molecule Nr-CAM is over-expressed in human brain tumors. Int J Cancer. 1998;76:451–8.

    Article  CAS  PubMed  Google Scholar 

  26. Singh SK, Clarke ID, Hide T, Dirks PB. Cancer stem cells in nervous system tumors. Oncogene. 2004;23:7267–73.

    Article  CAS  PubMed  Google Scholar 

  27. Song L, Huang Q, Chen K, Liu L, Lin C, Dai T, et al. miR-218 inhibits the invasive ability of glioma cells by direct downregulation of IKK-beta. Biochem Biophys Res Commun. 2010;402:135–40.

    Article  CAS  PubMed  Google Scholar 

  28. Jin J, Cai L, Liu ZM, Zhou XS. miRNA-218 inhibits osteosarcoma cell migration and invasion by down-regulating of TIAM1, MMP2 and MMP9. Asian Pac J Cancer Prev. 2013;14:3681–4.

    Article  PubMed  Google Scholar 

Download references

Acknowledgments

This work is supported by the Project Supported by the Natural Science Basic Research Plan in Shaanxi Province of China (Program No. 2013JQ3017), National Natural Science Foundation of China (No. 81272801 and No. 81271290), National Key Basic Research Program of China (“973” Project) (2010CB933900), scientific research program funded by Shaanxi Provincial Health Department (Program No. 2014D21 and 2014D24), Scientific Research Program Funded by Shaanxi Provincial Education Department (Program No. 14JK1617), and Program for Youth Science and Technology Star of Shaanxi Province (2014KJXX-76).

Conflicts of interest

None

Author information

Authors and Affiliations

  1. Institute of Basic Medicine Science, Xi’an Medical University, 1 Xin Wang Road, Xi’an, 710021, China

    Xingchun Gao, Yajing Mi & Weilin Jin

  2. Institute of Nano Biomedicine and Engineering, Department of Instrument Science and Engineering, Key Lab. for Thin Film and Microfabrication Technology of Ministry of Education, School of Electronic Information and Electronic Engineering, Shanghai Jiao Tong University, Shanghai, 200240, China

    Xingchun Gao, Yue Ma & Weilin Jin

  3. School of Life Sciences and Biotechnology, Shanghai Jiao Tong University, 800 Dong Chuan Road, Shanghai, 200240, China

    Weilin Jin

Authors
  1. Xingchun Gao
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Yajing Mi
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Yue Ma
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Weilin Jin
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding authors

Correspondence to Xingchun Gao or Weilin Jin.

Additional information

Xingchun Gao and Yajing Mi contributed equally to this work.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Gao, X., Mi, Y., Ma, Y. et al. LEF1 regulates glioblastoma cell proliferation, migration, invasion, and cancer stem-like cell self-renewal. Tumor Biol. 35, 11505–11511 (2014). https://doi.org/10.1007/s13277-014-2466-z

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s13277-014-2466-z

Keywords

Search

Navigation